Q3 2019 PURE Biosciences Inc Earnings Call
Edited Transcript of PURE earnings conference call or presentation 13-Jun-19 8:30pm GMT
Q3 2019 PURE Biosciences Inc Earnings Call
PURE Bioscience Reports Fiscal 2019 Third Quarter and Nine-Month Financial Results
Update on SDC-Based Antimicrobial Food Safety Solutions
NEW YORK, NY / ACCESSWIRE / June 13, 2019 / PURE Bioscience, Inc. (OTCQX: PURE ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on June 13, 2019 at 4:30 PM Eastern...
PURE Bioscience Sets Fiscal 2019 Third Quarter and Nine-Month Financial Results Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 13, 2019 the Company will file its Form 10-Q shortly...
Edited Transcript of PURE earnings conference call or presentation 6-Mar-19 9:30pm GMT
Q2 2019 PURE Biosciences Inc Earnings Call
PURE Bioscience Reports Fiscal 2019 Second Quarter and Six-Month Financial Results
Update on SDC-Based Antimicrobial Food Safety Solutions
PURE Bioscience and SmartWash Solutions Announce Partnership for New Combined PURE Control®/SmartWash™ Anti
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and SmartWash Solutions announced a partnership for a revolutionary antimicrobial...
PURE Bioscience Sets Fiscal 2019 Second Quarter and Six-Month Financial Results Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 6, 2019 the Company will file its Form 10-Q shortly...
Edited Transcript of PURE earnings conference call or presentation 25-Oct-18 8:30pm GMT
Full Year 2018 PURE Biosciences Inc Earnings Call
Edited Transcript of PURE earnings conference call or presentation 13-Dec-18 9:30pm GMT
Q1 2019 PURE Biosciences Inc Earnings Call
Pure Global’s wholly owned subsidiary PureSinse is a pharmaceutical-grade Licensed Producer of cannabis dedicated to developing new and innovative brands and products for the discerning Canadian consumer.
Our global strategy is to aggressively pursue and align with similarly spirited local and international cannabis companies that strengthen our position and influence in both the medical and anticipated adult-use markets.